AutoGenomics issued European patent for Human papillomavirus

NewsGuard 100/100 Score

AutoGenomics has announced that it has been issued a key European patent for Human papillomavirus.

Patent No.1 499 749 B1, "Human papillomavirus Detection with DNA Microarray," claims to be a method for detecting the presence of HPV using a microarray.

"This patent is the result of our collaboration with Dr. Erik Thunnissen, a prominent clinician and opinion leader in the field of Human papillomavirus," said Mr. Fareed Kureshy, President and CEO of AutoGenomics.

He further said that "with increasing demands for alternative technologies to meet the evolving need for genotyping we are excited that we can offer an automated solution that can significantly enhance workflow efficiency in the laboratory".

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Multi-omics study offers insights into psoriasis treatment